In summary, we demonstrated that tumor-infiltrating CD8+ T cells in the combination group were more increased than that in the RCE or Oxa alone groups, and as a result, the anticancer effect on the CD8+ T cell-mediated killing of CRC cells was significantly increased. This evidence concerns the gene CD8A and neoplasm.